Mitondra Therapeutics
PrivateCompany Overview
Mitondra Therapeutics operates in Healthcare & Life Sciences and is based in Cardiff. It was founded in 2025.
Mitondra Therapeutics is a biotechnology company that develops first-in-class small-molecule therapies to restore mitochondrial health by stimulating mitophagy.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Mitondra Therapeutics Comparables
Compare Mitondra Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| MitoRx Therapeutics | 85% | |
| Vincere Biosciences | 83% | |
| Capacity Bio | 83% |
For institutional investors. Book with your work email.
Mitondra Therapeutics Funding Rounds
Historical fundraising activity
Mitondra Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Mitondra Therapeutics's valuation, stock price, and market status.
Is Mitondra Therapeutics a public or private company?
Mitondra Therapeutics is a private company.
What is the current stock price of Mitondra Therapeutics?
Mitondra Therapeutics is a private company, so its shares have no public market price. Caplight tracks Mitondra Therapeutics's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Mitondra Therapeutics worth (valuation)?
Valuation information for Mitondra Therapeutics is not publicly available.
Can I buy Mitondra Therapeutics stock?
Mitondra Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Mitondra Therapeutics's last funding round?
Funding round information for Mitondra Therapeutics is not publicly available.
Who are the main investors in Mitondra Therapeutics?
Investor information for Mitondra Therapeutics is not publicly disclosed.
Will Mitondra Therapeutics IPO soon?
No public IPO plans have been announced for Mitondra Therapeutics.
How can I track Mitondra Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades in Mitondra Therapeutics's shares on secondary markets.